Alunbrig, illustration of tablet form (not a photo of the actual pack)

Illustrative image.

Alunbrig

Brigatinib

Prescription required

$5355.00

30mg · 3 × 30 tablets · 3 months supply

BrandBranded medicine· By Takeda

$1785.00 per month

How long a supply?

1 month$1785.00 a month
3 months$1785.00 a month
6 months$1785.00 a month
Supplied from Israel

Test mode: no payment is taken. View cart

Annual cost

$21420a year at this pack size

Prescription required

Upload your prescription after ordering, or send it to our pharmacy team. We dispense only against a valid prescription.

About Alunbrig

Overview

Alunbrig contains brigatinib, a kinase inhibitor supplied as film-coated tablets. It treats adults with ALK-positive non-small cell lung cancer that has spread to other parts of the body, with ALK-positive status confirmed by an FDA-approved test. It works by blocking ALK activity and related signals that help cancer cells grow.

What it treats

Treatment of adults with ALK-positive metastatic non-small cell lung cancer (NSCLC), confirmed by an FDA-approved test.

Safety information

Side effects

Common side effects of Alunbrig include diarrhea, tiredness, nausea, rash, cough, muscle pain, headache, high blood pressure, vomiting and shortness of breath. Contact your doctor promptly for new or worsening breathing symptoms, particularly during the first week of treatment, as these may indicate serious lung inflammation. Also report any changes in vision, muscle pain or weakness, or skin reactions after sun exposure. Other serious risks include high blood pressure, a slow heartbeat, increased creatine phosphokinase (CPK, a muscle enzyme), increased pancreatic enzymes, liver injury and high blood sugar. Regular blood pressure and heart rate checks and blood tests are needed to monitor for these problems. Alunbrig can also increase sensitivity to sunlight; limit sun exposure during treatment. Alunbrig can harm an unborn baby. If you could become pregnant, use effective contraception.

When to call your doctor

• New or worsening cough or shortness of breath, especially during the first week of treatment. • New vision problems or changes in your eyesight. • Unexplained muscle pain or weakness. • An unusually slow heartbeat.

If symptoms are severe or getting worse quickly, seek emergency care rather than waiting.

Before taking this medicine

The FDA label lists no formal contraindications for Alunbrig (brigatinib). However, it has important warnings and requires monitoring during treatment. Conditions requiring caution include lung inflammation, high blood pressure, a slow heart rate, vision changes, muscle pain or weakness with raised creatine phosphokinase (CPK), raised pancreatic enzymes, liver injury, high blood sugar and sensitivity to sunlight. Report new or worsening breathing symptoms promptly, especially during the first week, and tell your prescriber about any vision changes. Limit sun exposure. Your healthcare team should monitor blood pressure, heart rate, blood sugar, liver function, CPK and pancreatic enzymes. Severe liver or kidney impairment requires a dose adjustment by your prescriber. Alunbrig can harm an unborn baby. Females who could become pregnant should use effective contraception. Do not breastfeed during treatment.

Interactions

Avoid taking Alunbrig with medicines that strongly or moderately inhibit or induce CYP3A. These medicines can interact with Alunbrig. Ask your doctor to check for these interactions before starting another medicine. If taking them together cannot be avoided, your prescriber may need to adjust your Alunbrig dose.

Using Alunbrig

Dosing

Dosing is set by your prescriber. Each health care professional may prescribe medication differently according to a patient's medical history and condition, so follow the directions on your prescription label and speak to your doctor or pharmacist before changing anything.

Storage

Store below 25°C in a dry place, in the original pack, away from direct light and moisture. Do not keep it in a bathroom. Keep all medicines out of the sight and reach of children.

Clinical information on this page is summarised from the US FDA label ALUNBRIG (BRIGATINIB) TABLET, FILM COATED ALUNBRIG (BRIGATINIB) KIT [TAKEDA PHARMACEUTICALS AMERICA, INC.] (DailyMed, retrieved 19 September 2026).

Reviews

No reviews yet. Mail Order Drugs opened recently, and we publish reviews only from verified customers of this site, so this space stays empty until real ones arrive.

  • Every prescription order is checked by a licensed pharmacist before dispensing.
  • Payment pages are encrypted and card details never reach our servers.
  • We ship internationally, with cold-chain packing where a medicine needs it.

Related medicines